Iqvia Holdings (IQV) Retained Earnings (2011 - 2026)
Iqvia Holdings' (IQV) quarterly Retained Earnings came in at $8.0 billion in Q2 2026, up 20.9% year-over-year from $6.6 billion in Q2 2025, and up 3.33% quarter-over-quarter from $7.7 billion in Q1 2026.
Analysis
Iqvia Holdings (IQV) Retained Earnings (2011 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Retained Earnings across 16 years of filings, most recently posting $8.0 billion for Q2 2026.
- In Q2 2026, Retained Earnings rose 20.9% year-over-year to $8.0 billion; the TTM figure through Jun 2026 stood at $8.0 billion (up 20.9% YoY), while the FY2025 annual figure was $7.4 billion, up 22.42% from the prior year.
- Retained Earnings came in at $8.0 billion for Q2 2026 at Iqvia Holdings, up from $7.7 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $8.0 billion in Q2 2026 to a low of $2.6 billion in Q1 2022.
- Average Retained Earnings over 5 years is $5.2 billion, with a median of $5.2 billion recorded in 2024.
- Year-over-year, Retained Earnings soared 72.46% in 2022 and climbed 20.9% in 2026.
- Over 5 years, Retained Earnings stood at $3.3 billion in 2022, then jumped by 40.73% to $4.7 billion in 2023, then rose by 29.26% to $6.1 billion in 2024, then advanced by 22.42% to $7.4 billion in 2025, then gained by 7.14% to $8.0 billion in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were $8.0 billion in Q2 2026, $7.7 billion in Q1 2026, and $7.4 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 7.96 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -511.37 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 2.30 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 1.37 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.14 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 1.71 Bn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 6.70 Bn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -81.50 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -106.74 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -357.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.96 Bn |
| Mar 31, 2026 | 7.70 Bn |
| Dec 31, 2025 | 7.43 Bn |
| Sep 30, 2025 | 6.91 Bn |
| Jun 30, 2025 | 6.58 Bn |
| Mar 31, 2025 | 6.31 Bn |
| Dec 31, 2024 | 6.07 Bn |
| Sep 30, 2024 | 5.63 Bn |
| Jun 30, 2024 | 5.34 Bn |
| Mar 31, 2024 | 4.98 Bn |
| Dec 31, 2023 | 4.69 Bn |
| Sep 30, 2023 | 4.22 Bn |
| Jun 30, 2023 | 3.92 Bn |
| Mar 31, 2023 | 3.62 Bn |
| Dec 31, 2022 | 3.33 Bn |
| Sep 30, 2022 | 3.11 Bn |
| Jun 30, 2022 | 2.82 Bn |
| Mar 31, 2022 | 2.57 Bn |
| Dec 31, 2021 | 2.24 Bn |
| Sep 30, 2021 | 1.93 Bn |